Concepedia

Carlos E. Peredo

CE

Statistics

Publications

3

Citations

207

H-Index

3

Active since

2016

Affiliations

GlaxoSmithKline (United States)(Current)

GlaxoSmithKline (United Kingdom)

Research Triangle Park Foundation

Carlos E. Peredo is an author at GlaxoSmithKline (United States).

ORCID

Publications per year

2016–2021

3

Publications

3

Early Activation of Th2/Th22 Inflammatory and Pruritogenic Pathways in Acute Canine Atopic Dermatitis Skin Lesions

Thierry Olivry, David Mayhew, Judy S. Paps et al. · Journal of Investigative Dermatology · 2016 · 109 citations

Development of a Topical Treatment for Psoriasis Targeting RORγ: From Bench to Skin

Susan Smith, Carlos E. Peredo, Yukimasa Takeda et al. · PLoS ONE · 2016 · 80 citations · Full text

Engineering Cancer Antigen-Specific T Cells to Overcome the Immunosuppressive Effects of TGF-β

Jonathan D. Silk, Rachel J.M. Abbott, Katherine J. Adams et al. · The Journal of Immunology · 2021 · 18 citations · Full text

1–3 of 3